Caitlin John, LLC Aquestive Therapeutics, Inc. Transaction History
Caitlin John, LLC
- $151 Billion
- Q4 2024
A detailed history of Caitlin John, LLC transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Caitlin John, LLC holds 5,900 shares of AQST stock, worth $19,588. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,900
Previous 6,400
7.81%
Holding current value
$19,588
Previous $30.9 Million
32.05%
% of portfolio
0.01%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding AQST
# of Institutions
122Shares Held
46.9MCall Options Held
174KPut Options Held
143K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$32.6 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$18.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.35MShares$14.4 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY2.63MShares$8.73 Million1.54% of portfolio
-
Franklin Resources Inc San Mateo, CA2.13MShares$7.09 Million0.0% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $177M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...